Avenue Therapeutics

-$0.04 (-2.19%) Today
+$0.04 (+2.23%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATXI and other ETFs, options, and stocks.

About ATXI

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain.

CEO
Lucy Lu
Employees
4
Headquarters
New York, New York
Founded
2015

ATXI Key Statistics

Market Cap
69.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
161.58K
High Today
$1.86
Low Today
$1.75
Open Price
$1.80
Volume
75.14K
52 Week High
$12.34
52 Week Low
$1.75

ATXI Earnings

-$0.33
-$0.22
-$0.11
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 13, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure